Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Wegovy has been FDA-approved since June 2021 for chronic weight management in adults with a BMI of 30 or above, or 27 and above with a weight-related comorbidity
Month 3 Summary: The Transformation Begins Weight loss: 4-8 pounds this month (15-19 pounds total, 7-9% of starting weight) Side effects: Dramatically improved from month 2 Energy: Normalized to near-baseline levels Discontinuation rate: Only 2-3% stop during month 3 (completion probability high) Psychological state: Confident, encouraged, sustainable feeling Key achievement: Completed dose escalation successfully
PMID: 32690803
Reducing Inflammation: Mitigates inflammation, which aids in faster recovery and pain relief
I brought magnesium citrate with me on my honeymoon just in case I had a flare-up and needed to treat myself
